A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent/recurrent loco-regional or metastatic anal cancer

Squamous cell carcinoma of the anorectal canal (SCCA) is a rare HPV-related malignancy that is steadily increasing in incidence. A high unmet need exists for patients with persistent loco-regional and metastatic disease. Axalimogene filolisbac (ADXS11-001) is an investigational immunotherapy that st...

Descripción completa

Detalles Bibliográficos
Autores principales: Eng, Cathy, Fakih, Marwan, Amin, Manik, Morris, Van, Hochster, Howard S., Boland, Patrick M., Uronis, Hope
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170499/
https://www.ncbi.nlm.nih.gov/pubmed/32341753
http://dx.doi.org/10.18632/oncotarget.27536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170499/
https://www.ncbi.nlm.nih.gov/pubmed/32341753
http://dx.doi.org/10.18632/oncotarget.27536

Ejemplares similares